Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Digital Biomanufacturing Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The digital biomanufacturing market size has seen rapid expansion over recent years. This market is projected to expand from $23.97 billion in 2025 to $27.25 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.6%. Historically, this expansion is primarily driven by the growth of biologics production, the need for process efficiency, the adoption of automation in pharma manufacturing, a regulatory focus on quality compliance, and increasing manufacturing complexity.
The digital biomanufacturing market size is projected to experience swift expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $46.02 billion, demonstrating a compound annual growth rate (CAGR) of 14.0%. Factors contributing to this projected growth include the wider application of cell and gene therapies, the embrace of continuous manufacturing processes, the incorporation of AI into bioprocessing, the drive for quicker market entry, and funding directed towards intelligent biomanufacturing sites. Notable trends expected during this period encompass optimizing bioprocesses through data, automating biomanufacturing tasks, implementing digital twin technology, monitoring processes in real-time, and utilizing AI for quality control.
Download A Free Sample Report For Comprehensive Market Insights:
Digital Biomanufacturing Market Growth Drivers: What Factors Are Accelerating Expansion?
The expanding pharmaceutical industry is projected to propel the growth of digital biomanufacturing. This sector, responsible for researching, developing, and producing medicines, plays a vital role in healthcare by ensuring the availability of safe and effective treatments. Its expansion is fueled by rising global demand for healthcare services and medications, driven by an expanding and aging population, which necessitates increased production and innovation in drug development. Digital biomanufacturing supports the pharmaceutical industry by incorporating advanced data analytics, automation, and real-time monitoring to streamline drug production processes, enhance quality control, lower manufacturing expenses, and accelerate the development of reliable therapies. For instance, data from November 2024, as reported by the European Federation of Pharmaceutical Industries and Associations (EFPIA), indicated that in 2024, North America constituted 54.8% of the estimated global pharmaceutical sales, while Europe accounted for 22.7%. Furthermore, Europe invested an estimated €55,000 million in R&D in 2024. Consequently, the burgeoning pharmaceutical industry is a key driver for the digital biomanufacturing market.
Digital Biomanufacturing Market Segment Analysis And Revenue Opportunities
The digital biomanufacturing market covered in this report is segmented –
1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And Internet Of Things (IoT) Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing
Digital Biomanufacturing Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Leading companies in the digital biomanufacturing market are focusing on developing innovative technologies such as single use bioreactors to enhance the efficiency, scalability, and flexibility of biologics production processes. Single-use bioreactors are a type of bioreactor specifically designed for single-use applications in biomanufacturing, which removes the need for cleaning and sterilization between batches, while also providing flexibility, reducing contamination risks, and streamlining the production of biologics and vaccines. For instance, in March 2025, the European Commission, a Belgium based government agency, inaugurated the Biotech and Biomanufacturing Hub. This dedicated online platform supports biotech and biomanufacturing companies across the EU, especially startups and SMEs, by offering one stop access to funding programmes, regulatory guidance, intellectual property support, pilot and testing infrastructure, and networking tools. It also functions as a vital element of the Commission’s “Boosting Biotechnology and Biomanufacturing in the EU” strategy, which aims to strengthen Europe’s biotech ecosystem, increase competitiveness, reduce dependence on external supply chains, and streamline the journey from innovation to commercialisation for biotech-based products.
Digital Biomanufacturing Market Leading Players Shaping Industry Direction
Major companies operating in the digital biomanufacturing market are Sanofi SA; Thermo Fisher Scientific Inc.; Honeywell International Inc.; SAP SE; Danaher Corporation; ABB AG; Siemens Healthineers AG; Emerson Electric Co; GE HealthCare Technologies Inc.; Atos SE; Agilent Technologies Inc.; Cytiva Europe GmbH; Lonza Group AG; Dassault Systèmes SE; Sartorius AG; Pall Corporation; Eppendorf AG; Symphony Innovation LLC; Koch Membrane Systems Inc.; Culture Biosciences Inc.; Bota Biosciences Inc.; Shimadzu Corporation; e-MSion; Immersciobio GmbH
Access The Complete Digital Biomanufacturing Market Report:
Digital Biomanufacturing Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the digital biomanufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.